There are currently no approved disease-modifying osteoarthritis drugs (DMOADs) and only symptom relief treatments are available.

Watch Yi He present how our biomarkers have the potential to aid Osteoarthritis drug development in various stages.

Learn more

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.